当前位置：
X-MOL 学术
›
Ther. Adv. Med. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data
Therapeutic Advances in Medical Oncology ( IF 4.9 ) Pub Date : 2019-06-04 , DOI: 10.1177/1758835919853954 Margherita Ratti 1 , Jens Claus Hahne 2 , Laura Toppo 3 , Emanuela Castelli 4 , Fausto Petrelli 5 , Rodolfo Passalacqua 1 , Sandro Barni 5 , Gianluca Tomasello 1 , Michele Ghidini 6
Therapeutic Advances in Medical Oncology ( IF 4.9 ) Pub Date : 2019-06-04 , DOI: 10.1177/1758835919853954 Margherita Ratti 1 , Jens Claus Hahne 2 , Laura Toppo 3 , Emanuela Castelli 4 , Fausto Petrelli 5 , Rodolfo Passalacqua 1 , Sandro Barni 5 , Gianluca Tomasello 1 , Michele Ghidini 6
Affiliation
Since the beginning of its development, 5-fluorouracil (5-FU) has played a central role in the therapy of many solid cancers and is still a common therapeutic option especially in metastatic and adjuvant setting of colorectal and gastric tumours.1,2
中文翻译：
左叶酸二钠的重大创新和临床应用：可获得的临床前和临床数据回顾
自开发以来，5-氟尿嘧啶（5-FU）在许多实体癌的治疗中起着核心作用，并且仍然是常见的治疗选择，尤其是在结直肠癌和胃癌的转移性和辅助性环境中。1,2
更新日期：2019-06-04
中文翻译：
左叶酸二钠的重大创新和临床应用：可获得的临床前和临床数据回顾
自开发以来，5-氟尿嘧啶（5-FU）在许多实体癌的治疗中起着核心作用，并且仍然是常见的治疗选择，尤其是在结直肠癌和胃癌的转移性和辅助性环境中。1,2
京公网安备 11010802027423号